Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Netherlands Cancer Institute, Amsterdam, The Netherlands

Egbert Smit

Egbert Smit is Professor of Pulmonary Medicine, with an emphasis on Pulmonary Oncology, at the Netherlands Cancer Institute, Department of Thoracic Oncology in Amsterdam, The Netherlands.

After completing his PhD thesis involving multidisciplinary studies in medical oncology, genetics and pulmonary medicine in 1990, Professor Smit became a Board-Certified pulmonologist in 1997. Since 1986, he has been involved in research and clinical trials ranging from chemoprevention of lung cancer to the treatment of advanced non-small-cell lung cancer. He has been the principal investigator of several national and international phase II and III trials.

In recent years, Professor Smit has focused his research on translational oncology and molecular imaging. This has resulted in over 300 contributions to peer-reviewed journals and book publications, as well as participation in multiple online educational NSCLC resources.
Professor Smit is also active in several national and international societies such as the IASLC, ASCO, the American Association of Cancer Research (AACR) and the EORTC. He served as Chair of a multidisciplinary task force for the development of clinical guidelines in small-cell lung cancer in The Netherlands and has been a member of the European Society of Medical Oncology Lung and other thoracic tumours Faculty Group since 2011.
He is also on the review board of several leading oncology journals and has co-organised a number of national meetings on thoracic oncology and postgraduate teaching courses. Professor Smit has been involved as a promoter and co-reader for over 20 PhD students.